Filter
1038
Text search:
hazard
approach
Featured
123
294
Language
Document type
451
185
175
113
60
31
11
7
2
2
1
Countries
50
42
38
30
24
20
20
19
15
15
14
12
12
11
11
10
10
10
8
8
7
7
7
7
7
7
6
6
6
6
5
5
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
284
198
75
55
23
18
14
1
Toolboxes
115
90
78
69
50
47
43
40
37
33
31
27
24
24
23
18
16
14
9
7
6
5
4
3
2
1
1
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
DHS Analytical Studies No. 57
